Related Experiment Video

Updated: Jul 10, 2026

Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip
13:34

Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip

Published on: September 29, 2012

Midregion PTHrP regulates Rip1 and caspase expression in MDA-MB231 breast cancer cells

Claudio Luparello1, Rosalia Sirchia, Bruna Lo Sasso

  • 1Dipartimento di Biologia Cellulare e dello Sviluppo, Università di Palermo, Viale delle Scienze, 90128, Palermo, Italy. clupar@tin.it

Breast Cancer Research and Treatment
|November 22, 2007
PubMed

Insights

The parathyroid hormone-related protein (PTHrP) domain (38-94)-amide induces apoptosis in breast cancer cells by upregulating key cell death genes and activating caspases. This highlights a novel regulatory role for PTHrP in cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The midregion of parathyroid hormone-related protein (PTHrP) domain (38-94)-amide has shown potential in restraining cancer growth and invasion.
  • Previous studies indicated PTHrP's nuclear import and DNA-binding capabilities in MDA-MB231 breast cancer cells.
  • The precise mechanisms by which PTHrP influences apoptosis-related gene expression remain to be fully elucidated.

Purpose of the Study:

  • To investigate the effect of PTHrP (38-94)-amide on the expression of apoptosis factors and caspases in MDA-MB231 breast cancer cells.
  • To explore the role of Rip1 in mediating PTHrP-induced changes in caspase expression.
  • To identify novel regulatory pathways involved in apoptosis in breast cancer.

Main Methods:

  • Multiplex PCR and semi-quantitative PCR techniques were used to analyze gene expression.
  • Antisense oligonucleotide (asODN) transfections were employed to modulate gene expression.
  • Proliferation/invasion assays and protein analyses were conducted to assess cellular effects.

Main Results:

  • PTHrP treatment significantly up-regulated the expression of Bcl-xS, Bad, and Rip1.
  • Expression of caspase-2, -5, -6, -7, and -8 was induced by PTHrP in MDA-MB231 cells.
  • Down-regulation of Rip1 using asODN led to increased caspase up-regulation, partly via JNK inactivation.

Conclusions:

  • PTHrP (38-94)-amide modulates the expression of critical apoptosis-related genes and activates multiple caspases in breast cancer cells.
  • Rip1 plays a role in the transcriptional regulation of caspases, potentially through JNK signaling.
  • These findings offer new insights into the role of PTHrP in regulating apoptosis and suggest potential therapeutic targets in breast cancer treatment.

More Related Videos

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model09:03

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.